Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls
Abstract Inherited germline pathogenic variants are responsible for ~5% of breast cancer globally. Through rapid expansion and isolation since immigration in the early 17th century, French Canadians are a relatively genetically homogenous founder population and therefore represent a unique demograph...
Guardado en:
Autores principales: | Supriya Behl, Nancy Hamel, Manon de Ladurantaye, Stéphanie Lepage, Réjean Lapointe, Anne-Marie Mes-Masson, William D. Foulkes |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b67ddaa5e9f64dcabd8141ee8ac1639b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development
por: Yanying Huo, et al.
Publicado: (2021) -
Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma
por: Shoko Takeuchi, et al.
Publicado: (2018) -
Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases.
por: Ana Blanco, et al.
Publicado: (2013) -
Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7 in a hospital-based series of German patients with triple-negative breast cancer.
por: Franziska Pern, et al.
Publicado: (2012) -
RNF168-mediated localization of BARD1 recruits the BRCA1-PALB2 complex to DNA damage
por: John J. Krais, et al.
Publicado: (2021)